Bacterin International Holdings
Belgrade
About Bacterin International Holdings
Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products. Using designs focused on efficacy and safety for the patient, and functionality and ease of use for the surgeon, our innovative products fulfill niche needs in the industry. Our Biologics Division, has revolutionized the handling characteristics of allograft bone while maintaining many of the benefits that are native functions of autograft bone. Our OsteoSponge® product line has a highly osteoconductive matrix that is essential for neovascularization and bone formation, while exhibiting osteoinductive properties by exposing native BMP’s and growth factors. In addition to OsteoSponge®, Bacterin Biologics has an allograft portfolio designed specifically to meet the needs of the Spine, Cranio-maxillofacial, reconstructive, and trauma markets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $37.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2014)
- Ticker: nysemkt:BONE
- Website: bacterin.com
- Phone: 406-388-0480
Industries & Categories
Biotechnology, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bacterin-international-holdings-3685889 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.